BioAtla BCAB
OTC BCAB
$1.45 +0.12 (+9.02%)
As of: Oct 21, 2026 · 12:24 PM EDT

BioAtla (BCAB) FCF Margin (2020 - 2026)

Updated

BioAtla's FCF Margin came in at -6.45% for Q2 2026.

Analysis

BioAtla (BCAB) FCF Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioAtla reported FCF Margin of -276.26%, up 199.40 percentage points year-over-year; for FY2025, it was -2410.20%, down 1756.24 percentage points from FY2024.

  • FCF Margin carries a five-year change of +6196.79 percentage points (FY2020 to FY2025).
  • Going back by year, FCF Margin was -653.96% in FY2024 and -25255.20% in FY2021 (-16648.21 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.82%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 18.33%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 26.96%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.55%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.70%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 44.00%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.01%
10 BioAtla 2.41 Mn -16.54 Mn - -6.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.45%
Dec 31, 2025 -395.75%
Sep 30, 2024 -46.65%
Jun 30, 2024 -2,132.56%
Jun 30, 2021 -5,512.00%
Sep 30, 2020 -10,380.67%
Jun 30, 2020 -1,641.05%
Mar 31, 2020 -4,307.87%
API Access

BioAtla FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=BCAB&period=max&api_key=YOUR_API_KEY